{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:57:43Z","timestamp":1772830663050,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Brazilian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0010.00 RS"],"award-info":[{"award-number":["01 06 0010.00 RS"]}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0212.00 BA"],"award-info":[{"award-number":["01 06 0212.00 BA"]}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0300.00 ES"],"award-info":[{"award-number":["01 06 0300.00 ES"]}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0278.00 MG"],"award-info":[{"award-number":["01 06 0278.00 MG"]}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0115.00SP"],"award-info":[{"award-number":["01 06 0115.00SP"]}]},{"name":"Brazilian Ministry of Science and Technology","award":["01 06 0071.00 RJ"],"award-info":[{"award-number":["01 06 0071.00 RJ"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.atherosclerosis.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T18:20:20Z","timestamp":1523557220000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: Is it time to change?"],"prefix":"10.1016","volume":"274","author":[{"given":"Fabiano A.","family":"Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chams B.","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo C.P.","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia M.G.","family":"Fedeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Castilhos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhi M.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-1350","authenticated-orcid":false,"given":"Pedro G.","family":"Vidigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A\u00a0meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MOL.0000000000000237","article-title":"Non-high-density lipoprotein cholesterol: current status as cardiovascular marker","volume":"26","author":"Verbeek","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1373\/clinchem.2010.154773","article-title":"Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population","volume":"57","author":"van Deventer","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib5","first-page":"129","article-title":"2013ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"24","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib7","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"4 Suppl 1","key":"10.1016\/j.atherosclerosis.2018.04.007_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5935\/abc.2013S010","article-title":"V\u00a0Brazilian guidelines on dyslipidemias and prevention of atherosclerosis","volume":"101","author":"Xavier","year":"2013","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2013full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"National heart, lung, and blood institute, American college of cardiology foundation, American heart association: implications of recent clinical trials for the National cholesterol education Program adult treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib11","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2013.07.045","article-title":"Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study [very large database of lipids]","volume":"62","author":"Elshazly","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jacl.2013.11.001","article-title":"Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults","volume":"8","author":"Kilgore","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non\u2013HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"332","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"issue":"Suppl C","key":"10.1016\/j.atherosclerosis.2018.04.007_bib16","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1093\/eurheartj\/suw009","article-title":"Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidemia","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.numecd.2013.05.002","article-title":"Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update","volume":"23","author":"Reiner","year":"2013","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/HCO.0b013e328353fed5","article-title":"Low-density lipoprotein-lowering strategies: target versus maximalist versus population percentile","volume":"27","author":"Sniderman","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian longitudinal study of adult Health (ELSA-Brasil): objectives and design","volume":"175","author":"Aquino","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2018.04.007_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0034-8910.2013047003807","article-title":"Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil","volume":"47","author":"Fedeli","year":"2013","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacl.2011.05.004","article-title":"Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement","volume":"5","author":"Contois","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacl.2008.06.013","article-title":"National Lipid Association Taskforce on Non-HDL Cholesterol, the importance of non-HDL cholesterol reporting in lipid management","volume":"2","author":"Blaha","year":"2008","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2015.04.810","article-title":"Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 individuals in Hungary","volume":"241","author":"Mark","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.04.007_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amjcard.2012.10.037","article-title":"Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS with Rosuvastatin [LUNAR] Trial)","volume":"111","author":"Ballantyne","year":"2013","journal-title":"Am. J. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018301813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018301813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T17:02:53Z","timestamp":1604163773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018301813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":28,"alternative-id":["S0021915018301813"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: Is it time to change?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}